Back
Cimpress PLC 10K Form
Sell
47
CMPR
Cimpress PLC
Last Price:
48.67
Seasonality Move:
-3.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-01-28 | 10Q | CMPR/Cimpress PLC Quarterly |
2020-10-29 | 10Q | CMPR/Cimpress PLC Quarterly |
2020-08-11 | 10K | CMPR/Cimpress PLC Annual |
2020-05-06 | 10Q | CMPR/Cimpress PLC Quarterly |
2020-01-30 | 10Q | CMPR/Cimpress PLC Quarterly |
2019-10-31 | 10Q | CMPR/Cimpress PLC Quarterly |
Receive CMPR News And Ratings
See the #1 stock for the next 7 days that we like better than CMPR
CMPR Financial Statistics
Sales & Book Value
Annual Sales: | $2.89B |
---|---|
Cash Flow: | $-13.33M |
Price / Cash Flow: | 28.26 |
Annual Sales: | $-25.17 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -9.36000 |
---|---|
Net Income (TTM): | $-245.37M |
Gross Margin: | $1.39B |
Return on Equity: | 0% |
Return on Assets: | -11.99% |
Cimpress PLC Earnings Forecast
Key Cimpress PLC Financial Ratios
- The Gross Profit Margin over the past 22 years for CMPR is 48.30%.
- The Selling, General & Administrative Expenses for CMPR have been equal to 34.17% of Gross Profit Margin.
- The Research & Development expenses have been 10.14% of Revenue.
- The Interest Expense is -183.01% of Operating Income.
- The Net Earning history of CMPR is -1.88% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 14 years.
Cimpress PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Advertising Agencies |
Sector: | Communication Services |
Current Symbol: | CMPR |
CUSIP: | N20146 |
Website: | cimpress.com |
Debt
Debt-to-Equity Ratio: | -2.56 |
---|---|
Current Ratio: | 0.7 |
Quick Ratio: | 0.37 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CMPR Technical Analysis vs Fundamental Analysis
Sell
47
Cimpress PLC (CMPR)
is a Sell
Is Cimpress PLC a Buy or a Sell?
-
Cimpress PLC stock is rated a Sell
The current Cimpress PLC [CMPR] share price is $51.04. The Score for CMPR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.